Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 2;80(3):78. doi: 10.1007/s00018-023-04715-w

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

PMC Copyright notice

Fig. 2 — Chronic inflammatory arthropathies in which IFN-inducible CXCR3 ligands have been implicated. Prevalence, symptomatology, role and disease marker potential of the IFN-inducible CXCR3 ligands in A RA, JIA, AOSD and B in spondyloarthritis, septic arthritis and osteoarthritis. Prevalence numbers were based on [114–119]. Global prevalence of septic arthritis has not been described recently, whereas incidence of septic arthritis was recently reported to be 21/100,000 person-years in New Zealand with pronounced interethnic variation [120]. AOSD adult-onset Still’s disease, CA crystal-induced arthritis, CXCL CXCL chemokine receptor ligand, DMARDs disease-modifying anti-rheumatic drugs, HC healthy control, JIA juvenile idiopathic arthritis, MAS macrophage activation syndrome, N.A. not available in literature, OA osteoarthritis, PsA psoriatic arthritis, RA rheumatoid arthritis, RF rheumatoid factor, S. aureus Staphylococcus aureus, SF synovial fluid, sJIA systemic juvenile idiopathic arthritis, ST synovial tissue, TNF-α tumor necrosis factor α, TJI traumatic joint injury

Fig. 2 — Chronic inflammatory arthropathies in which IFN-inducible CXCR3 ligands have been implicated. Prevalence, symptomatology, role and disease marker potential of the IFN-inducible CXCR3 ligands in A RA, JIA, AOSD and B in spondyloarthritis, septic arthritis and osteoarthritis. Prevalence numbers were based on [114–119]. Global prevalence of septic arthritis has not been described recently, whereas incidence of septic arthritis was recently reported to be 21/100,000 person-years in New Zealand with pronounced interethnic variation [120]. AOSD adult-onset Still’s disease, CA crystal-induced arthritis, CXCL CXCL chemokine receptor ligand, DMARDs disease-modifying anti-rheumatic drugs, HC healthy control, JIA juvenile idiopathic arthritis, MAS macrophage activation syndrome, N.A. not available in literature, OA osteoarthritis, PsA psoriatic arthritis, RA rheumatoid arthritis, RF rheumatoid factor, S. aureus Staphylococcus aureus, SF synovial fluid, sJIA systemic juvenile idiopathic arthritis, ST synovial tissue, TNF-α tumor necrosis factor α, TJI traumatic joint injury